Informed consent | • | | | | |
Patient characteristics | • | | | | |
SpO2 | • | • | • | • | • |
6-min walk test | • | • | • | • | • |
Endurance time | • | • | • | | • |
SGRQ and CAT | • | • | • | | • |
Dyspnoea-12 | • | • | • | | • |
HADS | • | • | • | | • |
Pedometer | • | • | • | | • |
Pulmonary function test | • | • | • | • | • |
ECG | • | • | • | • | • |
Nintedanib medication diary | • | During the study period |
Adverse events | | During the study period |